JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
|
+$1.58B |
| 2 |
Vanguard FTSE Europe ETF
VGK
|
+$1B |
| 3 |
CPGX
COLUMBIA PIPELINE GROUP IN COM STK (DE)
CPGX
|
+$958M |
| 4 |
Eli Lilly
LLY
|
+$776M |
| 5 |
AGN
Allergan plc
AGN
|
+$751M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.23B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.98B |
| 3 |
Johnson & Johnson
JNJ
|
+$1.31B |
| 4 |
Merck
MRK
|
+$837M |
| 5 |
Bread Financial
BFH
|
+$630M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 20.59% |
| 2 | Financials | 15.13% |
| 3 | Healthcare | 11.59% |
| 4 | Technology | 11.09% |
| 5 | Consumer Discretionary | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2176
CALL
AerCap
AER
$22.6B
| $4.41M | ﹤0.01% |
115,300
+95,300
| +477% | +$4.21M |
2015 Q2
1 quarter
|
|
2177
iShares US Financials ETF
IYF
$3.92B
| $4.41M | ﹤0.01% |
104,770
+87,546
| +508% | +$3.9M |
2013 Q2
9 quarters
|
|
2178
CALL
Prudential Financial
PRU
$39B
| $4.4M | ﹤0.01% |
57,716
+12,716
| +28% | +$1.07M |
2014 Q3
4 quarters
|
|
|
MON
2179
CALL
DELISTED
Monsanto Co
MON
| $4.39M | ﹤0.01% |
51,500
+47,200
| +1,098% | +$4.66M |
2014 Q3
4 quarters
|
|
2180
WSFS Financial
WSFS
$3.91B
| $4.39M | ﹤0.01% |
152,519
-79,189
| -34% | -$2.23M |
2013 Q2
9 quarters
|
|
|
HRG
2181
DELISTED
HRG Group, Inc.
HRG
| $4.39M | ﹤0.01% |
374,349
+325,443
| +665% | +$4.25M |
2015 Q2
1 quarter
|
|
|
VTAE
2182
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
| $4.39M | ﹤0.01% |
398,793
+158,393
| +66% | +$1.68M |
2014 Q3
4 quarters
|
|
|
CCP
2183
DELISTED
Care Capital Properties, Inc.
CCP
| $4.39M | ﹤0.01% |
+133,224
| New | +$4.31M |
2015 Q3
0 quarters
|
|
2184
Clearway Energy Class C
CWEN
$5.98B
| $4.39M | ﹤0.01% |
377,905
+108,474
| +40% | +$1.87M |
2013 Q3
8 quarters
|
|
|
KERX
2185
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $4.38M | ﹤0.01% |
1,243,199
-552,252
| -31% | -$3.7M |
2013 Q2
9 quarters
|
|
|
SUNE
2186
CALL
DELISTED
SUNEDISON, INC COM
SUNE
| $4.37M | ﹤0.01% |
609,200
-761,600
| -56% | -$13.7M |
2014 Q3
4 quarters
|
|
|
DPLO
2187
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $4.37M | ﹤0.01% |
+152,167
| New | +$6.51M |
2015 Q3
0 quarters
|
|
2188
CALL
Kimberly-Clark
KMB
$31.4B
| $4.36M | ﹤0.01% |
40,000
| – | – |
2014 Q3
4 quarters
|
|
|
2189
PUT
Kimberly-Clark
KMB
$31.4B
| $4.36M | ﹤0.01% |
40,000
| – | – |
2014 Q3
4 quarters
|
|
2190
Prothena Corp
PRTA
$438M
| $4.36M | ﹤0.01% |
96,198
+9,972
| +12% | +$581K |
2014 Q4
3 quarters
|
|
2191
PTC Therapeutics
PTCT
$5.35B
| $4.36M | ﹤0.01% |
163,360
+23,022
| +16% | +$985K |
2014 Q3
4 quarters
|
|
|
JSD
2192
DELISTED
NUVEEN SHORT DURATION CREDIT OPPORTUNITIES FUND
JSD
| $4.36M | ﹤0.01% |
286,765
+5,074
| +2% | +$81.4K |
2014 Q4
3 quarters
|
|
2193
Ingles Markets
IMKTA
$1.61B
| $4.36M | ﹤0.01% |
91,089
-17,380
| -16% | -$855K |
2015 Q1
2 quarters
|
|
2194
CRA International
CRAI
$1.1B
| $4.36M | ﹤0.01% |
201,850
+9,650
| +5% | +$228K |
2015 Q1
2 quarters
|
|
2195
First Trust NASDAQ Technology Dividend Index Fund
TDIV
$4.47B
| $4.34M | ﹤0.01% |
179,348
-2,710
| -1% | -$68.6K |
2013 Q2
9 quarters
|
|
2196
Great Southern Bancorp
GSBC
$851M
| $4.34M | ﹤0.01% |
100,276
+1,100
| +1% | +$45.6K |
2013 Q2
9 quarters
|
|
|
ALPN
2197
DELISTED
Alpine Immune Sciences Inc
ALPN
| $4.32M | ﹤0.01% |
83,243
+9,595
| +13% | +$630K |
2015 Q2
1 quarter
|
|
2198
Zillow
ZG
$6.39B
| $4.3M | ﹤0.01% |
149,763
-31,527
| -17% | -$843K |
2013 Q2
9 quarters
|
|
2199
Nuveen Floating Rate Income Fund
JFR
$1.2B
| $4.29M | ﹤0.01% |
427,000
| – | – |
2014 Q4
3 quarters
|
|
|
RPT
2200
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $4.29M | ﹤0.01% |
285,869
+26,750
| +10% | +$433K |
2013 Q2
9 quarters
|
|
Similar funds
JP Morgan Chase's Q3 2015 Portfolio in Review
As of Q3 2015, JP Morgan Chase held 4,367 positions worth $374B, down 12% from $424B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase withdrew a net $18B in Q3 2015, closing 488 positions and reducing 1,582 holdings. Its most notable exit was ROCK-TENN COMPANY CL-A, an estimated $559M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, JP Morgan Chase opened a new position in COLUMBIA PIPELINE GROUP IN COM STK (DE) worth $672M.
- JP Morgan Chase's largest Q3 2015 buy was COLUMBIA PIPELINE GROUP IN COM STK (DE): 36,762,567 shares worth $672M.
- JP Morgan Chase added most to Xtrackers MSCI EAFE Hedged Equity ETF in Q3 2015, an estimated $1.58B increase.
- JP Morgan Chase's biggest Q3 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.23B.
- JP Morgan Chase fully exited ROCK-TENN COMPANY CL-A in Q3 2015, selling an estimated $559M.
- JP Morgan Chase's ten largest holdings make up 17% of its $374B portfolio in Q3 2015.
- JP Morgan Chase opened 374 new positions and closed 488 in Q3 2015.
- JP Morgan Chase's portfolio value fell 12% quarter-over-quarter to $374B.
Based on JP Morgan Chase's 13F filing for Q3 2015, filed 13 Nov 2015.